Hormone releasing intrauterine system should be used more widely in primary care for menorrhagia, study concludes
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f100 (Published 09 January 2013) Cite this as: BMJ 2013;346:f100- Zosia Kmietowicz
- 1BMJ
Women with menorrhagia reported more improvement in bleeding and quality of life with the levonorgestrel releasing intrauterine system than with other treatments available in primary care, a two year study in England has found.1
Women fitted with the levonorgestrel releasing intrauterine system (also known as LNG-IUS or Mirena) were also more likely to stick with treatment, found the study, called the Effectiveness and Cost-Effectiveness of Levonorgestrel-Containing Intrauterine System in Primary Care against Standard Treatment for Menorrhagia (ECLIPSE) study.
Researchers from the Universities of Birmingham and Nottingham randomised 571 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.